Breast cancer study asks: skip the Pre-Med after two safe doses?
Symptom relief
Not yet recruiting
This study looks at whether breast cancer patients can safely stop taking premedication (drugs to prevent allergic reactions) after two well-tolerated doses of weekly paclitaxel chemotherapy. The goal is to see if stopping these extra drugs improves quality of life, since they ca…
Phase: NA • Sponsor: Charles LeMoyne Hospital • Aim: Symptom relief
Last updated May 18, 2026 11:59 UTC